<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:podcast="https://podcastindex.org/namespace/1.0" xmlns:media="http://search.yahoo.com/mrss/" version="2.0"><channel><title>Mini Podcast: Complex Assay Development</title><link>https://www.spreaker.com/podcast/mini-podcast-complex-assay-development--5941518</link><description><![CDATA[Veeda Clinical Research Limited (“Veeda”) together with its subsidiary, Bioneeds India Private Limited (“Bioneeds”), and its joint venture, Ingenuity Biosciences Private Limited (“Ingenuity”), (together referred to as the “Veeda Group”) offers a comprehensive portfolio of clinical, preclinical and bio/analytical services to support innovator, biosimilar and generic drug development programs of our global clientele.]]></description><atom:link href="https://www.spreaker.com/show/5941518/episodes/feed" rel="self" type="application/rss+xml"/><language>en</language><category>Health &amp; Fitness</category><copyright>Copyright Veeda Lifesciences</copyright><image><url>https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/5d1714774a3dc36484464f3abb99e8a0.jpg</url><title>Mini Podcast: Complex Assay Development</title><link>https://www.spreaker.com/podcast/mini-podcast-complex-assay-development--5941518</link></image><lastBuildDate>Thu, 27 Feb 2025 05:02:41 +0000</lastBuildDate><itunes:author>Veeda Lifesciences</itunes:author><itunes:owner><itunes:name>Veeda Lifesciences</itunes:name><itunes:email>veeda8475@gmail.com</itunes:email></itunes:owner><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/5d1714774a3dc36484464f3abb99e8a0.jpg"/><itunes:subtitle>Veeda Clinical Research Limited (“Veeda”) together with its subsidiary, Bioneeds India Private Limited (“Bioneeds”), and its joint venture, Ingenuity Biosciences Private Limited (“Ingenuity”), (together referred to as the “Veeda Group”) offers a...</itunes:subtitle><itunes:summary><![CDATA[Veeda Clinical Research Limited (“Veeda”) together with its subsidiary, Bioneeds India Private Limited (“Bioneeds”), and its joint venture, Ingenuity Biosciences Private Limited (“Ingenuity”), (together referred to as the “Veeda Group”) offers a comprehensive portfolio of clinical, preclinical and bio/analytical services to support innovator, biosimilar and generic drug development programs of our global clientele.]]></itunes:summary><itunes:category text="Health &amp; Fitness"/><itunes:explicit>clean</itunes:explicit><itunes:type>episodic</itunes:type><item><title>Mini-Podcast on First-in-Human Trial for Vitiligo</title><link>https://www.spreaker.com/episode/mini-podcast-on-first-in-human-trial-for-vitiligo--60544853</link><description><![CDATA[Join us in this enlightening episode as we delve into the world of biologics, biosimilars, and vaccines with Veeda Biopharma. Discover how <a href="https://www.veedacr.com/" target="_blank" rel="noreferrer noopener"><b>Veeda</b></a> Biopharma's comprehensive and integrated development solutions are paving the way for advancements in these critical areas of healthcare. Our expert guests from Veeda Biopharma will share insights into their innovative approaches, from early-stage research and development to clinical trials and regulatory approvals. Learn about the challenges and opportunities in the biologics and biosimilars space, and how Veeda Biopharma is driving progress to ensure safe, effective, and accessible treatments. Whether you're a healthcare professional, researcher, or simply interested in the future of medicine, this episode offers valuable knowledge and inspiration. Tune in to explore the cutting-edge developments shaping the future of biologics, biosimilars, and vaccines.<br /><br /><br /><br /><br />]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/60544853</guid><pubDate>Sat, 29 Jun 2024 05:14:49 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/60544853/mini_podcast_on_first_in_human_trial_for_vitiligo.mp3" length="8663502" type="audio/mpeg"/><itunes:author>Veeda Lifesciences</itunes:author><itunes:subtitle>Join us in this enlightening episode as we delve into the world of biologics, biosimilars, and vaccines with Veeda Biopharma. Discover how https://www.veedacr.com/ Biopharma's comprehensive and integrated development solutions are paving the way for...</itunes:subtitle><itunes:summary><![CDATA[Join us in this enlightening episode as we delve into the world of biologics, biosimilars, and vaccines with Veeda Biopharma. Discover how <a href="https://www.veedacr.com/" target="_blank" rel="noreferrer noopener"><b>Veeda</b></a> Biopharma's comprehensive and integrated development solutions are paving the way for advancements in these critical areas of healthcare. Our expert guests from Veeda Biopharma will share insights into their innovative approaches, from early-stage research and development to clinical trials and regulatory approvals. Learn about the challenges and opportunities in the biologics and biosimilars space, and how Veeda Biopharma is driving progress to ensure safe, effective, and accessible treatments. Whether you're a healthcare professional, researcher, or simply interested in the future of medicine, this episode offers valuable knowledge and inspiration. Tune in to explore the cutting-edge developments shaping the future of biologics, biosimilars, and vaccines.<br /><br /><br /><br /><br />]]></itunes:summary><itunes:duration>542</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/5d1714774a3dc36484464f3abb99e8a0.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Mini-Podcast on Navigating Bioanalytical Challenges_ Unbound Paclitaxel Quantification</title><link>https://www.spreaker.com/episode/mini-podcast-on-navigating-bioanalytical-challenges-unbound-paclitaxel-quantification--60244543</link><description><![CDATA[Welcome to "Navigating Bioanalytical Challenges," the podcast that delves into the intricate world of bioanalysis and the innovative solutions driving the field forward. In this episode, we explore the critical topic of unbound paclitaxel quantification, a cornerstone in cancer treatment research and drug development.<br />Join our expert hosts as they discuss the significance of measuring unbound paclitaxel levels, the challenges faced by researchers, and the latest advancements in bioanalytical techniques. We will unpack the complexities of this essential process, including sample preparation, analytical methods, and data interpretation, providing listeners with a comprehensive understanding of the subject.<br />Whether you're a seasoned professional or a curious newcomer to the field, this episode offers valuable insights into the tools and strategies that are shaping the future of bioanalysis. Tune in to learn how accurate quantification of unbound paclitaxel can enhance therapeutic outcomes and drive innovation in oncology.<br />]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/60244543</guid><pubDate>Sat, 01 Jun 2024 05:58:29 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/60244543/mini_podcast_on_navigating_bioanalytical_challenges_unbound_paclitaxel_quantification_1.mp3" length="5708205" type="audio/mpeg"/><itunes:author>Veeda Lifesciences</itunes:author><itunes:subtitle>Welcome to "Navigating Bioanalytical Challenges," the podcast that delves into the intricate world of bioanalysis and the innovative solutions driving the field forward. In this episode, we explore the critical topic of unbound paclitaxel...</itunes:subtitle><itunes:summary><![CDATA[Welcome to "Navigating Bioanalytical Challenges," the podcast that delves into the intricate world of bioanalysis and the innovative solutions driving the field forward. In this episode, we explore the critical topic of unbound paclitaxel quantification, a cornerstone in cancer treatment research and drug development.<br />Join our expert hosts as they discuss the significance of measuring unbound paclitaxel levels, the challenges faced by researchers, and the latest advancements in bioanalytical techniques. We will unpack the complexities of this essential process, including sample preparation, analytical methods, and data interpretation, providing listeners with a comprehensive understanding of the subject.<br />Whether you're a seasoned professional or a curious newcomer to the field, this episode offers valuable insights into the tools and strategies that are shaping the future of bioanalysis. Tune in to learn how accurate quantification of unbound paclitaxel can enhance therapeutic outcomes and drive innovation in oncology.<br />]]></itunes:summary><itunes:duration>238</itunes:duration><itunes:keywords>505(b)(2)genericdrugdevelopmen,complexgenericsdevelopmentserv,earlyphaseclinicaldevelopment,earlyphaseclinicaltrials,lc-msbioanalysisservices,phaseiiclinicaltrials,phaseistudyinpatients</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/049c707bb272a30d7009776e1abcf922.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Mini-Podcast on First-in-Human Trial for Vitiligo</title><link>https://www.spreaker.com/episode/mini-podcast-on-first-in-human-trial-for-vitiligo--59727920</link><description><![CDATA[Dive into the groundbreaking realm of dermatology with our mini-podcast on the First-in-Human Trial for Vitiligo. Join us as we explore the latest advancements in vitiligo research, shedding light on the journey from preclinical studies to the first human trials. Discover the science behind this innovative treatment approach, the potential impact on patients' lives, and the challenges faced in bringing novel therapies to market. Whether you're a healthcare professional, researcher, or simply curious about the future of dermatological care, this mini-podcast promises to enlighten and inspire.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/59727920</guid><pubDate>Tue, 30 Apr 2024 11:42:47 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/59727920/mini_podcast_on_first_in_human_trial_for_vitiligo.mp3" length="8663502" type="audio/mpeg"/><itunes:author>Veeda Lifesciences</itunes:author><itunes:subtitle>Dive into the groundbreaking realm of dermatology with our mini-podcast on the First-in-Human Trial for Vitiligo. Join us as we explore the latest advancements in vitiligo research, shedding light on the journey from preclinical studies to the first...</itunes:subtitle><itunes:summary><![CDATA[Dive into the groundbreaking realm of dermatology with our mini-podcast on the First-in-Human Trial for Vitiligo. Join us as we explore the latest advancements in vitiligo research, shedding light on the journey from preclinical studies to the first human trials. Discover the science behind this innovative treatment approach, the potential impact on patients' lives, and the challenges faced in bringing novel therapies to market. Whether you're a healthcare professional, researcher, or simply curious about the future of dermatological care, this mini-podcast promises to enlighten and inspire.]]></itunes:summary><itunes:duration>542</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/5d1714774a3dc36484464f3abb99e8a0.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Mini-Podcast on Navigating Bioanalytical Challenges_ Unbound Paclitaxel Quantification</title><link>https://www.spreaker.com/episode/mini-podcast-on-navigating-bioanalytical-challenges-unbound-paclitaxel-quantification--59226817</link><description><![CDATA[Tune in to our mini-podcast where we delve into the intricacies of quantifying unbound Paclitaxel, a critical aspect of bioanalytical research. Join us as we navigate the challenges associated with accurately measuring unbound Paclitaxel levels in biological samples. From discussing method development hurdles to exploring innovative techniques, this podcast offers valuable insights for researchers and professionals in the field. Gain practical tips and expert advice to overcome bioanalytical challenges and optimize your quantification strategies for unbound Paclitaxel.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/59226817</guid><pubDate>Sat, 30 Mar 2024 06:24:23 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/59226817/mini_podcast_on_navigating_bioanalytical_challenges_unbound_paclitaxel_quantification.mp3" length="5708414" type="audio/mpeg"/><itunes:author>Veeda Lifesciences</itunes:author><itunes:subtitle>Tune in to our mini-podcast where we delve into the intricacies of quantifying unbound Paclitaxel, a critical aspect of bioanalytical research. Join us as we navigate the challenges associated with accurately measuring unbound Paclitaxel levels in...</itunes:subtitle><itunes:summary><![CDATA[Tune in to our mini-podcast where we delve into the intricacies of quantifying unbound Paclitaxel, a critical aspect of bioanalytical research. Join us as we navigate the challenges associated with accurately measuring unbound Paclitaxel levels in biological samples. From discussing method development hurdles to exploring innovative techniques, this podcast offers valuable insights for researchers and professionals in the field. Gain practical tips and expert advice to overcome bioanalytical challenges and optimize your quantification strategies for unbound Paclitaxel.]]></itunes:summary><itunes:duration>238</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/5d1714774a3dc36484464f3abb99e8a0.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Podcast_ Veeda Biopharma's Integrated Development Solutions for Biologics, Biosimilars and Vaccines</title><link>https://www.spreaker.com/episode/podcast-veeda-biopharma-s-integrated-development-solutions-for-biologics-biosimilars-and-vaccines--58872880</link><description><![CDATA[Welcome to "Veeda Biopharma's Integrated Development Solutions for Biologics, Biosimilars, and Vaccines," where we delve into the dynamic world of pharmaceuticals and cutting-edge advancements in the field. Join us as we navigate the intricate landscape of biopharmaceutical development with experts from Veeda Biopharma, a leading player in the industry.In each episode, we unravel the complexities of developing biologics, biosimilars, and vaccines, exploring the latest innovations, regulatory considerations, and breakthroughs that shape the future of healthcare. Our discussions feature insightful conversations with industry leaders, scientists, and regulatory professionals who share their expertise and experiences in the ever-evolving realm of biopharmaceuticals.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/58872880</guid><pubDate>Thu, 29 Feb 2024 05:23:51 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/58872880/podcast_veeda_biopharma_s_integrated_development_solutions_for_biologics_biosimilars_and_vaccines.mp3" length="9345286" type="audio/mpeg"/><itunes:author>Veeda Lifesciences</itunes:author><itunes:subtitle>Welcome to "Veeda Biopharma's Integrated Development Solutions for Biologics, Biosimilars, and Vaccines," where we delve into the dynamic world of pharmaceuticals and cutting-edge advancements in the field. Join us as we navigate the intricate...</itunes:subtitle><itunes:summary><![CDATA[Welcome to "Veeda Biopharma's Integrated Development Solutions for Biologics, Biosimilars, and Vaccines," where we delve into the dynamic world of pharmaceuticals and cutting-edge advancements in the field. Join us as we navigate the intricate landscape of biopharmaceutical development with experts from Veeda Biopharma, a leading player in the industry.In each episode, we unravel the complexities of developing biologics, biosimilars, and vaccines, exploring the latest innovations, regulatory considerations, and breakthroughs that shape the future of healthcare. Our discussions feature insightful conversations with industry leaders, scientists, and regulatory professionals who share their expertise and experiences in the ever-evolving realm of biopharmaceuticals.]]></itunes:summary><itunes:duration>585</itunes:duration><itunes:keywords>bioequivalenceofgenericdermato,covid19vaccinetrials,smallmoleculeanalysis</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/5d1714774a3dc36484464f3abb99e8a0.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Mini Podcast: Identifying the Right Investigators and Patients for your Vaccine Study</title><link>https://www.spreaker.com/episode/mini-podcast-identifying-the-right-investigators-and-patients-for-your-vaccine-study--58509312</link><description><![CDATA[In this mini podcast episode, we delve into the critical aspects of identifying the ideal investigators and patients for your vaccine study. Hosted by industry experts, this insightful discussion provides invaluable guidance for pharmaceutical professionals navigating the complex landscape of vaccine development.Tune in to discover essential strategies for selecting investigators with the expertise and resources necessary to execute your study effectively.<br /><br />Learn how to assess potential investigators' qualifications, track records, and capabilities to ensure the success of your vaccine trial.Moreover, gain valuable insights into the process of identifying and recruiting the right patients for your study. From demographic considerations to medical history assessments, our experts at <a href="https://www.veedacr.com/" target="_blank" rel="noreferrer noopener"><b>veeda </b></a>share practical tips to streamline patient selection and maximize the chances of obtaining meaningful data.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/58509312</guid><pubDate>Wed, 31 Jan 2024 05:05:48 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/58509312/mini_podcast_identifying_the_right_investigators_and_patients_for_your_vaccine_study_veeda.mp3" length="6137867" type="audio/mpeg"/><itunes:author>Veeda Lifesciences</itunes:author><itunes:subtitle>In this mini podcast episode, we delve into the critical aspects of identifying the ideal investigators and patients for your vaccine study. Hosted by industry experts, this insightful discussion provides invaluable guidance for pharmaceutical...</itunes:subtitle><itunes:summary><![CDATA[In this mini podcast episode, we delve into the critical aspects of identifying the ideal investigators and patients for your vaccine study. Hosted by industry experts, this insightful discussion provides invaluable guidance for pharmaceutical professionals navigating the complex landscape of vaccine development.Tune in to discover essential strategies for selecting investigators with the expertise and resources necessary to execute your study effectively.<br /><br />Learn how to assess potential investigators' qualifications, track records, and capabilities to ensure the success of your vaccine trial.Moreover, gain valuable insights into the process of identifying and recruiting the right patients for your study. From demographic considerations to medical history assessments, our experts at <a href="https://www.veedacr.com/" target="_blank" rel="noreferrer noopener"><b>veeda </b></a>share practical tips to streamline patient selection and maximize the chances of obtaining meaningful data.]]></itunes:summary><itunes:duration>256</itunes:duration><itunes:keywords>covid19vaccinetrials,phaseiiclinicaltrials,phaseiiiclinicaltrial,phaseiiivaccinetrial</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/23f7ba8fdab8f6ffa908076cc3e5ca91.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Mini-Podcast on Building Trust in Clinical Trials_ Veeda's Purposeful Tech Integration</title><link>https://www.spreaker.com/episode/mini-podcast-on-building-trust-in-clinical-trials-veeda-s-purposeful-tech-integration--58153197</link><description><![CDATA[Explore the vital topic of "Building Trust in Clinical Trials" in this insightful mini-podcast, where we delve into Veeda's purposeful tech integration. Discover the innovative strategies and technologies employed by Veeda to enhance transparency, reliability, and participant engagement in <a href="https://www.veedacr.com/" target="_blank" rel="noreferrer noopener"><b>clinical trials</b></a>. Join us for a brief yet impactful exploration of the intersection between trust-building and cutting-edge technology in the realm of clinical research.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/58153197</guid><pubDate>Sat, 30 Dec 2023 05:34:58 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/58153197/mini_podcast_on_building_trust_in_clinical_trials_veeda_s_purposeful_tech_integration.mp3" length="6300871" type="audio/mpeg"/><itunes:author>Veeda Lifesciences</itunes:author><itunes:subtitle>Explore the vital topic of "Building Trust in Clinical Trials" in this insightful mini-podcast, where we delve into Veeda's purposeful tech integration. Discover the innovative strategies and technologies employed by Veeda to enhance transparency,...</itunes:subtitle><itunes:summary><![CDATA[Explore the vital topic of "Building Trust in Clinical Trials" in this insightful mini-podcast, where we delve into Veeda's purposeful tech integration. Discover the innovative strategies and technologies employed by Veeda to enhance transparency, reliability, and participant engagement in <a href="https://www.veedacr.com/" target="_blank" rel="noreferrer noopener"><b>clinical trials</b></a>. Join us for a brief yet impactful exploration of the intersection between trust-building and cutting-edge technology in the realm of clinical research.]]></itunes:summary><itunes:duration>263</itunes:duration><itunes:keywords>earlyphaseclinicaldevelopment,earlyphaseclinicaltrials,phaseiiclinicaltrials,phaseistudyinpatients</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/5d1714774a3dc36484464f3abb99e8a0.jpg"/><itunes:episodeType>full</itunes:episodeType></item><item><title>Mini Podcast: Complex Assay Development | Method Development Challenges For Calcitriol</title><link>https://www.youtube.com/watch?v=nWtAYfu7W4c&amp;list=PL6u-bVBkxHiG1xDNawrF44WPNw9bqR4fn&amp;index=2</link><description><![CDATA[Veeda Clinical Research Limited (“Veeda”) together with its subsidiary, Bioneeds India Private Limited (“Bioneeds”), and its joint venture, Ingenuity Biosciences Private Limited (“Ingenuity”), (together referred to as the “Veeda Group”) offers a comprehensive portfolio of clinical, preclinical and bio/analytical services to support innovator, biosimilar and generic drug development programs of our global clientele.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/56613738</guid><pubDate>Mon, 28 Aug 2023 12:36:22 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/56613738/mini_podcast_complex_assay_development_method_development_challenges_for_calcitriol_veeda_1.mp3" length="1323395" type="audio/mpeg"/><itunes:author>Veeda Lifesciences</itunes:author><itunes:subtitle>Veeda Clinical Research Limited (“Veeda”) together with its subsidiary, Bioneeds India Private Limited (“Bioneeds”), and its joint venture, Ingenuity Biosciences Private Limited (“Ingenuity”), (together referred to as the “Veeda Group”) offers a...</itunes:subtitle><itunes:summary><![CDATA[Veeda Clinical Research Limited (“Veeda”) together with its subsidiary, Bioneeds India Private Limited (“Bioneeds”), and its joint venture, Ingenuity Biosciences Private Limited (“Ingenuity”), (together referred to as the “Veeda Group”) offers a comprehensive portfolio of clinical, preclinical and bio/analytical services to support innovator, biosimilar and generic drug development programs of our global clientele.]]></itunes:summary><itunes:duration>83</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/71e1f98a71f86f743de0361040a750b0.jpg"/><itunes:episodeType>full</itunes:episodeType></item></channel></rss>
